This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and Pfizer’s CEO. Critics say the Commission’s actions undermine public ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

Brian Coleman, Head of Enterprise Information Security at Pfizer, and winner of the Legalweek Leaders in Tech Law Award for Best Use of Artificial Intelligence which won the Best Use of Artificial ...

After coughing up nearly $24 million in a federal settlement over donations to patient charities, Pfizer went on the offensive last summer and took the U.S.' anti-kickbac | Pfizer is battling for ...

Pfizer's Direct Copay Assistance Program was designed to limit tafamidis cost-sharing to $35 a month for Medicare Part D enrollees with lower incomes.

A federal court has rejected Pfizer’s PFE claims against the government in a case with major implications for drug pricing. The pharmaceutical giant’s lawsuit against the U.S. Department of ...

Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents after a mixed ruling by London's High Court, with potential appeals and significant financial stakes involved.

The court held that DNH lacked legal standing and dismissed the challenge to Pfizer’s diversity program. The Second Circuit’s decision creates a potential roadblock for challenges levied by ...

Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies will likely take legal action against Medicare drug price negotiations, which aim to cut costs for older Americans, but will ...